Researchers in China report that global incidence rates of psoriasis rose slightly from 1990 to 2021 and are projected to ...
Sun Pharma introduces Ilumya in India for treatment of moderate-to-severe plaque psoriasis: Our Bureau, Mumbai Tuesday, December 2, 2025, 14:45 Hrs [IST] Sun Pharma has announced ...
North America and Western Europe — two wealthier regions of the world — reported the highest incidences and are projected to ...
“Our study demonstrated in a large real-world population that long-term treatment of up to 5 years with adalimumab in adult patients with psoriasis led to a sustained improvement in the practice of ...
Innovent's Pecondle, a recombinant anti-interleukin-23p19 subunit, receives China NMPA approval to treat moderate-to-severe plaque psoriasis: San Francisco Monday, December 1, 202 ...
Winter's chill can wreak havoc on skin, causing acne, dullness, and flare-ups of conditions like eczema. Experts advise ...
Mumbai-based Sun Pharma has introduced its global innovative biologic Ilumya (Tildrakizumab) in India for the treatment of moderate-to-seve.
13hon MSN
Hormone-disrupting chemicals from plastics shown to promote a chronic inflammatory skin condition
A Johns Hopkins Medicine study involving a dozen people with the inflammatory skin disease hidradenitis suppurativa (HS), ...
Sportschosun on MSN
Heel pain, why I shouldn't ignore it...A sign of cancer and arthritis?
The foot is the farthest part of the heart, but it contains an important signal of health. In particular, heel pain is a ...
Dry winter skin? Nutritionist Anushi Jain lists fruits, veggies, and healthy fats that help hydrate, repair, and keep skin ...
Company's immunology franchise demonstrates strong market momentum with preferred status under one of the largest pharmacy benefit managers in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback